Alzheimer’s disease CSF biomarkers: clinical indications and rational use

This review focusses on the validation and standardization of Alzheimer’s disease (AD) cerebrospinal fluid (CSF) biomarkers, as well as on the current clinical indications and rational use of CSF biomarkers in daily clinical practice. The validated AD CSF biomarkers, Aβ(1-42), T-tau, and P-tau(181),...

Descripción completa

Detalles Bibliográficos
Autores principales: Niemantsverdriet, Ellis, Valckx, Sara, Bjerke, Maria, Engelborghs, Sebastiaan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565643/
https://www.ncbi.nlm.nih.gov/pubmed/28752420
http://dx.doi.org/10.1007/s13760-017-0816-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565643/
https://www.ncbi.nlm.nih.gov/pubmed/28752420
http://dx.doi.org/10.1007/s13760-017-0816-5

Ejemplares similares